The stimulatory effect of 1,2-DHX on TNF-α production predicts a favorable outcome in melanoma treatment, since several reports have associated the use of TNF inhibitors with an increased risk of developing skin cancer, including melanoma [54,55]. Here, TNF is linked to skin neoplasm.